Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#29ABE2
Curious Blue
41, 171, 226
198, 76, 52
82, 24, 0, 11
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#162555
Blue Zodiac
22, 37, 85
226, 59, 21
74, 56, 0, 67
OncoSynergy is a clinical-stage immuno-oncology company based in Stamford, Connecticut, developing patient-focused immunotherapies for solid and hematologic cancers. Its research and development efforts address several difficult-to-treat conditions, including glioblastoma, the most common and malignant primary brain cancer; breast, ovarian and pancreatic cancers; malignant meningioma; and drug-resistant acute lymphoblastic leukemia.
The company’s therapeutic platforms include a first-in-class humanized and deimmunized pan-CD29 monoclonal antibody, OS2966, and a best-in-class humanized monoclonal antibody targeting PD1. OncoSynergy’s clinical program includes investigation of OS2966 for recurrent glioblastoma. The company announced the launch of a Phase I trial for these patients in 2020, followed by the first patient treated in its first-in-human clinical trial in 2021. In May 2024, the FDA granted OS2966 a third orphan drug designation, according to the company’s news updates.
OncoSynergy also shares information about its science, pipeline, mission, team, scientific advisory board, partners and collaborators. The company is located in Stamford, Connecticut, and provides contact information for inquiries.
Company type
Privately Held
Year founded
2011
Company size
2-10 employees
How do I download the OncoSynergy logo?
The OncoSynergy logo comes in two versions: a logo and an icon. Download as transparent PNG.
What are OncoSynergy's brand colors?
The OncoSynergy color palette uses the hex codes #29ABE2, #FFFFFF and #162555.
The OncoSynergy name, logos and brand assets are trademarks of OncoSynergy and its affiliates. Brandfetch isn't affiliated with or endorsed by OncoSynergy. Their use is subject to OncoSynergy's brand guidelines.
